Solvay Executive and Leadership Team

Melissa Tsutsumi, the Chief Financial Officer & Director, Procurement Coatis Gbu at Solvay, manages the company's financial health and procurement strategies. Overseeing all financial planning, reporting, and investment activities, Melissa Tsutsumi ensures fiscal responsibility and drives profitability. This critical role involves optimizing procurement processes for the Coatis GBU, securing cost-effective sourcing of raw materials and services. By analyzing market trends and financial data, the Chief Financial Officer & Director, Procurement Coatis Gbu identifies opportunities for financial growth and risk mitigation. This leadership position is integral to maintaining Solvay's strong financial standing and supporting its strategic expansion initiatives. The scope includes managing capital allocation, budgeting, and ensuring compliance with financial regulations across global operations. Tsutsumi's expertise in procurement directly impacts the efficiency and cost-effectiveness of key business units, contributing significantly to the company's bottom line and competitive advantage in the chemical sector.

Mary Bakken, the Executive Vice President, Chief Operating Officer at Solvay, directs global operational execution and efficiency. Overseeing manufacturing processes and supply chain logistics, Mary Bakken ensures seamless production across all facilities. This leadership role involves optimizing resource allocation and driving operational improvements to meet market demands. By implementing advanced manufacturing techniques, the Executive Vice President, Chief Operating Officer enhances product quality and delivery timelines. This focus on operational excellence directly supports Solvay's commitment to delivering high-value chemical solutions. The scope of this position encompasses managing large-scale industrial operations and fostering a culture of continuous improvement within the global workforce. Strategic alignment with corporate objectives guides all operational decisions, ensuring maximum output and minimal waste. The Executive Vice President, Chief Operating Officer's oversight extends to safety protocols and environmental compliance, reinforcing Solvay's dedication to responsible manufacturing.

Dan Pritchard, the President at Solvay, sets the overarching strategic direction for the organization. Guiding the company's vision and long-term objectives, Dan Pritchard ensures alignment across all business units and functional areas. This executive leadership position involves driving innovation and market expansion initiatives to solidify Solvay's industry leadership. By fostering key stakeholder relationships and championing corporate values, the President cultivates a robust and dynamic business environment. Pritchard's role is central to navigating complex market landscapes and capitalizing on emerging opportunities within the chemical sector. The scope of this presidency encompasses global market strategy, corporate development, and ensuring the company's sustained growth and competitive edge. This leadership function is paramount in translating strategic intent into tangible business outcomes, reinforcing Solvay's commitment to pioneering advancements and delivering exceptional value to customers worldwide.

Elizabeth Mutisya, the Vice President, US Medical Affairs and Chief Medical Officer at Solvay, leads the company's medical strategy and oversight within the United States. Overseeing clinical research, medical education, and health outcomes initiatives, Elizabeth Mutisya ensures adherence to the highest medical and ethical standards. This vital role involves translating scientific advancements into practical medical applications and providing expert medical guidance. By collaborating with healthcare professionals and regulatory bodies, the Vice President, US Medical Affairs and Chief Medical Officer strengthens Solvay's commitment to patient well-being and product safety. Mutisya's leadership is crucial in shaping the medical narrative and ensuring the responsible deployment of Solvay's chemical innovations in healthcare contexts. The scope includes managing medical teams, developing evidence-based strategies, and contributing to the company's overall mission of improving lives through science.